GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,040 | +33.3% | 12,000 | 0.0% | 0.02% | +42.9% |
| Q2 2023 | $17,280 | -31.4% | 12,000 | 0.0% | 0.01% | -36.4% |
| Q1 2023 | $25,200 | +85.8% | 12,000 | 0.0% | 0.02% | +175.0% |
| Q4 2022 | $13,560 | -32.2% | 12,000 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $20,000 | +25.0% | 12,000 | 0.0% | 0.01% | +42.9% |
| Q2 2022 | $16,000 | -15.8% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $19,000 | -24.0% | 12,000 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $25,000 | -46.8% | 12,000 | 0.0% | 0.01% | -47.1% |
| Q3 2021 | $47,000 | +23.7% | 12,000 | 0.0% | 0.02% | +21.4% |
| Q2 2021 | $38,000 | +46.2% | 12,000 | 0.0% | 0.01% | +40.0% |
| Q1 2021 | $26,000 | -7.1% | 12,000 | -4.6% | 0.01% | 0.0% |
| Q4 2020 | $28,000 | -12.5% | 12,575 | +4.8% | 0.01% | -23.1% |
| Q3 2020 | $32,000 | -13.5% | 12,000 | 0.0% | 0.01% | -23.5% |
| Q2 2020 | $37,000 | – | 12,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
| Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
| Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
| WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
| D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
| Virtu Financial LLC | 14,683 | $32,000 | 0.00% |